Update on direct-to-consumer marketing in oncology

Journal of Oncology Practice

Volumn 8, Issue 2, 2012, Pages 124-127

  Gray, Stacy W ^a   Abel, Gregory A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TAMOXIFEN;

AWARENESS; CANCER CENTER; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RESEARCH; CANCER SCREENING; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONSUMER; DIAGNOSTIC IMAGING; DIRECT TO CONSUMER MARKETING; DRUG METABOLISM; FOOD AND DRUG ADMINISTRATION; GENETIC SCREENING; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HUMAN; MANAGEMENT; MARKETING; MEDICAL DEVICE; MEDICAL SPECIALIST; MULTICENTER STUDY (TOPIC); NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; OFF LABEL DRUG USE; ONCOLOGY; PATIENT COUNSELING; PHARMACOGENETICS; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84865502445     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2011.000513     Document Type: Review

References (44)

1. Kontos EZ, Viswanath K: Cancer-related direct-to-consumer advertising: A critical review. Nat Rev Cancer 11:142-150, 2011
2. Lovett K, Liang B, Mackey T: Risks of online direct-to-consumer tumor markers for cancer screening. J Clin Oncol doi: 10.1200/JCO.2011.37.8984
3. Viswanath K: Science and society: The communications revolution and cancer control. Nat Rev Cancer 5:828-835, 2005
4. Kaplan RM, Frosch DL: Decision making in medicine and health care. Ann Rev Clin Psychol 1:525-56, 2005 (Pubitemid 43843961)
5. Eysenbach G: The impact of the Internet on cancer outcomes. CA Cancer J Clin 53:356-371, 2003
6. Nagler RH, Gray SW, Romantan A, et al: Differences in information seeking among breast, prostate, and colorectal cancer patients: Results from a population-based survey. Patient Educ Couns 81:S54-S62, 2010 (suppl)
7. Gray SW, Armstrong K, Demichele A, et al: Colon cancer patient information seeking and the adoption of targeted therapy for on-label and off-label indications. Cancer 115:1424-1434, 2009
8. Lee CJ, Gray SW, Lewis N: Internet use leads cancer patients to be active health care consumers. Patient Educ Couns 81:S63-S69, 2010 (suppl)
9. Wilkes MS, Bell RA, Kravitz RL: Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Health Aff (Millwood) 19:110-128, 2000
10. Howard HC, Pascal B: Is there a doctor in the house? The presence of physicians in the direct-to-consumer genetic testing context. J Community Genet [epub ahead of print on September 6, 2011]
11. Leachman BSA, MacArthur DG, Angrist M, et al: Direct-to-consumer genetic testing: Personalized medicine in evolution. Am Soc Clin Oncol Ed Book 34-40, 2011
12. Abel GA, Penson RT, Joffe S, et al: Direct-to-consumer advertising in oncology. Oncologist 11:217-226, 2006 (Pubitemid 43261768)
13. Jagsi R: Conflicts of interest and the physician-patient relationship in the era of direct-to-patient advertising. J Clin Oncol 25:902-905, 2007
14. Viale PH, Sanchez Yamamoto D: The attitudes and beliefs of oncology nurse practitioners regarding direct-to-consumer advertising of prescription medications. Oncol Nurs Forum 31:777-783, 2004
15. Abel GA, Lee SJ, Weeks JC: Direct-to-consumer advertising in oncology: A content analysis of print media. J Clin Oncol 25:1267-1271, 2007 (Pubitemid 46640574)
16. Abel GA, Burstein HJ, Hevelone ND, et al: Cancer-related direct-to-consumer advertising: Awareness, perceptions, and reported impact among patients undergoing active cancer treatment. J Clin Oncol 27:4182-4187, 2009
17. Atherly A, Rubin PH: The cost-effectiveness of direct-to-consumer advertising for prescription drugs. Med Care Res Rev 66:639-657, 2009
18. Spence MM, Teleki SS, Cheetham TC, et al: Direct-to-consumer advertising of COX-2 inhibitors: Effect on appropriateness of prescribing. Med Care Res Rev 62:544-559, 2005
19. Price RA, Frank RG, Cleary PD, et al: Effects of direct-to-consumer advertising and clinical guidelines on appropriate use of human papillomavirus DNA tests. Med Care 49:132-138, 2011
20. Larson RJ, Schwartz LM, Woloshin S, et al: Advertising by academic medical centers. Arch Intern Med 165:645-651, 2005 (Pubitemid 40393146)
21. Fenton JJ, Deyo RA: Patient self-referral for radiologic screening tests: Clinical and ethical concerns. J Am Board Fam Pract 16:494-501, 2003
22. Lee TH, Brennan TA: Direct-to-consumer marketing of high-technology screening tests. N Engl J Med 346:529-531, 2002 (Pubitemid 34441749)
23. Illes J, Fan E, Koenig BA, et al: Self-referred whole-body CT imaging: Current implications for health care consumers. Radiology 228:346-351, 2003 (Pubitemid 36910071)
24. Illes J, Kann D, Karetsky K, et al: Advertising, patient decision making, and self-referral for computed tomographic and magnetic resonance imaging. Arch Intern Med 164:2415-2419, 2004 (Pubitemid 39628067)
25. American College of Radiology: ACR Statement on CT Screening Exams. http://www.acr.org/SecondaryMainMenuCategories/quality-safety/RadSafety/ RadiationSafety/statement-CT-screening.aspx
26. American Medical Association, Council on Scientific Affairs (Reference Committee E): Report 10: Commercialized Medical Screening. http://www.ama-assn. org/resources/doc/csaph/a03csa10-fulltext.pdf
27. American Medical Association, Council on Ethical and Judicial Affairs: Report 3-A-05 Presented by Goldrich MS (2005). Direct-to-Consumer Diagnostic Imaging Tests, 2005. http://www.ama-assn.org/resources/doc/code-medical-ethics/ 8045a.pdf
28. Genetics & Public Policy Center: (2010). Direct-to-Consumer Genetic Testing Companies. http://www.dnapolicy.org/resources/ AlphabetizedDTCGeneticTestingCompanies11.10.pdf
29. Wolfberg AJ: Genes on the Web-direct-to-consumer marketing of genetic testing. New Engl J Med 355:543-545, 2006
30. Gray S, Olopade OI: Direct-to-consumer marketing of genetic tests for cancer: Buyer beware. J Clin Oncol 21:3191-3193, 2003
31. Gollust SE, Hull SC, Wilfond BS: Limitations of direct-to-consumer advertising for clinical genetic testing. JAMA 288:1762-1767, 2002
32. Javitt GH, Stanley E, Hudson K: Direct-to-consumer genetic tests, government oversight, and the First Amendment: What the government can (and can't) do to protect the public's health. Oklahoma Law Rev 57:251-302, 2004
33. Williams-Jones B: Where there's a web, there's a way: Commercial genetic testing and the Internet. Community Genet 6:46-57, 2003
34. Lachance CR, Erby LA, Ford BM, et al: Informational content, literacy demands, and usability of websites offering health-related genetic tests directly to consumers. Genet Med 12:304-312, 2010
35. Leighton JW, Valvered K, Bernhardt B: The general public's understanding and perception of direct-to-consumer genetic test results. Presented at the American Society of Human Genetics meeting, November 2-6, 2010, Washington, DC (abstr 1415)
36. Kaufman D, Murphy Bollinger J, Devaney S, et al: Direct from consumers: A survey of 1,048 customers of three direct-to-consumer personal genomic testing companies about motivations, attitudes, and responses to testing. Presented at the American Society of Human Genetics meeting. November 2-6, 2010, Washington, DC (abstr 390)
37. Sweeny K, Legg AM: Predictors of interest in direct-to-consumer genetic testing. Psychol Health 26:1259-1272, 2011
38. Gray SW, O'Grady C, Karp L, et al: Risk information exposure and direct-toconsumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev 18:1303-1311, 2009
39. Bloss CS, Schork NJ, Topol EJ: Effect of direct-to-consumer genomewide profiling to assess disease risk. New Engl J Med 364:524-534, 2011
40. McGuire AL, Evans BJ, Caulfield T, et al: Science and regulation. Regulating direct-to-consumer personal genome testing. Science 330:181-182, 2010
41. Hudson KL: Genomics, health care, and society. N Engl J Med 365:1033-1041, 2011
42. American Medical Association: Reports of the Board of Trustees, Annual Meeting June, 2008-Direct-to-Consumer Advertising and Provision of Genetic Testing, pp 64-77. http://www.ama-assn.org/resources/doc/hod/a08botreports.pdf
43. Hudson K, Javitt G, Burke W, et al: ASHG statement on direct-to-consumer genetic testing in the United States. Am J Hum Genet 81:635-637, 2007
44. Directors ACoMGBo: ACMG statement on direct-to-consumer genetic testing. Genet Med 6:60, 2004